RG-6244

N/A

Report date: 2023/12/20 11:56:08

NME

Base Information

Drug NameRG-6244

Drug Alias NameRG-6244GDC-4379

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTyrosine-protein kinase JAK1 inhibitors

TargetsTyrosine-protein kinase JAK1

Therapy Area/IndicationsAsthma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNew Zealand

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesGenentech Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesGenentech Inc

Active IndicationsN/A

Inactive IndicationsAsthma

ATC CodeN/A